MiniMed Group: Medtronic's Diabetes Business Does Not Convince

Group 1 - MiniMed Group, Inc. (MMED) shares have been trading lower following its public offering due to a weak reception of Medtronic's (MDT) diabetes business [1] - The public response to the diabetes segment of Medtronic has been described as very soft, impacting MiniMed's stock performance [1] Group 2 - The service "Value in Corporate Events" offers insights on major corporate events such as earnings reports, M&A, and IPOs, aiming to provide actionable investment ideas [2]